All Stories

  1. Pretesting strategies for homoscedasticity when comparing means. Their robustness facing non-normality

    Article • Communications in Statistics - Simulation and Computation, August 2019, Taylor & Francis

    Professor Jordi Ocaña

  2. Two‐stage designs versus scaled average designs in bioequivalence studies for highly variable drugs.

    Article • Statistics in Medicine, August 2017, Wiley

    Professor Jordi Ocaña, Eduard Molins Lleonart

  3. Consumer's risk in the EMA and FDA regulatory approaches for bioequivalence in highly variable drugs

    Article • Statistics in Medicine, December 2015, Wiley

    Professor Jordi Ocaña

  4. Carryover negligibility and relevance in bioequivalence studies

    Article • Pharmaceutical Statistics, July 2015, Wiley

    Professor Jordi Ocaña